dc.contributor.author | Bell, CG | en_US |
dc.contributor.author | Finer, S | en_US |
dc.contributor.author | Lindgren, CM | en_US |
dc.contributor.author | Wilson, GA | en_US |
dc.contributor.author | Rakyan, VK | en_US |
dc.contributor.author | Teschendorff, AE | en_US |
dc.contributor.author | Akan, P | en_US |
dc.contributor.author | Stupka, E | en_US |
dc.contributor.author | Down, TA | en_US |
dc.contributor.author | Prokopenko, I | en_US |
dc.contributor.author | Morison, IM | en_US |
dc.contributor.author | Mill, J | en_US |
dc.contributor.author | Pidsley, R | en_US |
dc.contributor.author | Deloukas, P | en_US |
dc.contributor.author | Frayling, TM | en_US |
dc.contributor.author | Hattersley, AT | en_US |
dc.contributor.author | McCarthy, MI | en_US |
dc.contributor.author | Beck, S | en_US |
dc.contributor.author | Hitman, GA | en_US |
dc.contributor.author | Int Type 2 Diabet 1q Consortium | en_US |
dc.date.accessioned | 2016-08-15T12:43:26Z | |
dc.date.available | 2010-10-27 | en_US |
dc.date.issued | 2010-11-18 | en_US |
dc.date.submitted | 2016-08-03T17:41:27.902Z | |
dc.identifier.issn | 1932-6203 | en_US |
dc.identifier.other | e14040 | |
dc.identifier.other | 10.1371/journal.pone.0014040 | |
dc.identifier.other | e14040 | |
dc.identifier.other | e14040 | |
dc.identifier.other | e14040 | en_US |
dc.identifier.other | e14040 | en_US |
dc.identifier.other | e14040 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/14550 | |
dc.description | This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | en_US |
dc.description.sponsorship | CGB and SB were funded by the Wellcome Trust (084071). AET was supported by a Heller Research Fellowship. CML is funded by WT086596/Z/08/Z (Wellcome Trust Research Career Development Fellowship). SF was funded by the Medical Research Council and Barts and the London Charity. Additional funding was from NIDDK (DK-073490). | en_US |
dc.format.extent | ? - ? | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | PLOS ONE | en_US |
dc.subject | GENOME-WIDE ASSOCIATION | en_US |
dc.subject | DNA METHYLATION | en_US |
dc.subject | HISTONE MODIFICATIONS | en_US |
dc.subject | TESTING ASSOCIATION | en_US |
dc.subject | POSITIVE SELECTION | en_US |
dc.subject | ADULT OBESITY | en_US |
dc.subject | VARIANTS | en_US |
dc.subject | DISEASE | en_US |
dc.subject | RISK | en_US |
dc.subject | EPIGENOMICS | en_US |
dc.title | Integrated Genetic and Epigenetic Analysis Identifies Haplotype-Specific Methylation in the FTO Type 2 Diabetes and Obesity Susceptibility Locus | en_US |
dc.type | Article | |
dc.rights.holder | © 2010 Bell et al. | |
dc.identifier.doi | 10.1371/journal.pone.0014040 | en_US |
pubs.issue | 11 | en_US |
pubs.notes | Not known | en_US |
pubs.volume | 5 | en_US |